AquaBounty Technologies (AQB) Competitors

$1.82
-0.01 (-0.55%)
(As of 04/24/2024 ET)

AQB vs. CLVR, TRVN, CANF, PSTV, PTIX, EFTR, TENX, GRAY, VVOS, and YMTX

Should you be buying AquaBounty Technologies stock or one of its competitors? The main competitors of AquaBounty Technologies include Clever Leaves (CLVR), Trevena (TRVN), Can-Fite BioPharma (CANF), Plus Therapeutics (PSTV), Protagenic Therapeutics (PTIX), eFFECTOR Therapeutics (EFTR), Tenax Therapeutics (TENX), Graybug Vision (GRAY), Vivos Therapeutics (VVOS), and Yumanity Therapeutics (YMTX). These companies are all part of the "medical" sector.

AquaBounty Technologies vs.

Clever Leaves (NASDAQ:CLVR) and AquaBounty Technologies (NASDAQ:AQB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, community ranking, media sentiment, earnings, dividends and risk.

AquaBounty Technologies has a consensus price target of $25.00, suggesting a potential upside of 1,273.63%. Given Clever Leaves' higher possible upside, analysts clearly believe AquaBounty Technologies is more favorable than Clever Leaves.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clever Leaves
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
AquaBounty Technologies
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

6.9% of Clever Leaves shares are owned by institutional investors. Comparatively, 8.9% of AquaBounty Technologies shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by company insiders. Comparatively, 2.3% of AquaBounty Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Clever Leaves has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500. Comparatively, AquaBounty Technologies has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500.

Clever Leaves has a net margin of -102.77% compared to Clever Leaves' net margin of -1,114.81%. Clever Leaves' return on equity of -15.68% beat AquaBounty Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Clever Leaves-102.77% -63.32% -49.91%
AquaBounty Technologies -1,114.81%-15.68%-13.84%

In the previous week, AquaBounty Technologies had 2 more articles in the media than Clever Leaves. MarketBeat recorded 2 mentions for AquaBounty Technologies and 0 mentions for Clever Leaves. AquaBounty Technologies' average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
Clever Leaves Neutral
AquaBounty Technologies Neutral

Clever Leaves has higher revenue and earnings than AquaBounty Technologies. Clever Leaves is trading at a lower price-to-earnings ratio than AquaBounty Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clever Leaves$17.42M0.39-$17.90M-$11.31-0.34
AquaBounty Technologies$2.47M2.84-$27.56M-$7.39-0.25

AquaBounty Technologies received 171 more outperform votes than Clever Leaves when rated by MarketBeat users. However, 81.25% of users gave Clever Leaves an outperform vote while only 64.56% of users gave AquaBounty Technologies an outperform vote.

CompanyUnderperformOutperform
Clever LeavesOutperform Votes
13
81.25%
Underperform Votes
3
18.75%
AquaBounty TechnologiesOutperform Votes
184
64.56%
Underperform Votes
101
35.44%

Summary

AquaBounty Technologies beats Clever Leaves on 9 of the 15 factors compared between the two stocks.

Get AquaBounty Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AQB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AQB vs. The Competition

MetricAquaBounty TechnologiesFishing, hunting & trapping IndustryMedical SectorNASDAQ Exchange
Market Cap$7.03M$7.03M$4.91B$7.48B
Dividend YieldN/A3.14%2.97%3.96%
P/E Ratio-0.259.24259.1720.61
Price / Sales2.842.842,392.9280.27
Price / CashN/A9.2146.6734.58
Price / Book0.040.044.664.30
Net Income-$27.56M$226.71M$103.69M$213.92M
7 Day Performance4.60%3.09%-0.26%1.26%
1 Month Performance-13.33%-11.05%-6.30%-4.19%
1 Year Performance-84.04%-46.62%7.96%7.75%

AquaBounty Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLVR
Clever Leaves
0 of 5 stars
$4.05
+5.5%
N/A-58.3%$7.09M$17.42M-0.36296Gap Up
TRVN
Trevena
1.7505 of 5 stars
$0.39
+5.4%
$9.00
+2,219.6%
-42.2%$7.11M$3.12M-0.1223Analyst Report
CANF
Can-Fite BioPharma
0 of 5 stars
$2.01
+1.5%
$15.00
+646.3%
N/A$7.12M$740,000.00-1.128Analyst Report
PSTV
Plus Therapeutics
1.1782 of 5 stars
$1.63
-1.8%
$10.00
+513.5%
-57.5%$6.98M$4.91M-0.0520Gap Down
PTIX
Protagenic Therapeutics
0 of 5 stars
$1.57
+25.6%
N/A-15.0%$6.97MN/A-1.37N/APositive News
Gap Down
High Trading Volume
EFTR
eFFECTOR Therapeutics
1.096 of 5 stars
$1.94
+9.0%
$24.00
+1,137.1%
-81.2%$7.16M$3.55M-0.1114Gap Down
TENX
Tenax Therapeutics
2.2019 of 5 stars
$3.53
-0.8%
$480.00
+13,497.7%
-86.8%$6.92MN/A0.005Positive News
Gap Up
GRAY
Graybug Vision
0 of 5 stars
$4.59
+1.8%
N/A+14.8%$7.21MN/A-2.6527High Trading Volume
VVOS
Vivos Therapeutics
0 of 5 stars
$2.65
+0.4%
N/A-71.9%$7.23M$13.80M-0.24154
YMTX
Yumanity Therapeutics
0 of 5 stars
$0.63
+21.0%
N/A-84.6%$6.89M$4.84M-0.2140News Coverage
Gap Up

Related Companies and Tools

This page (NASDAQ:AQB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners